Press Releases Advicenne

Equities

ALDVI

FR0013296746

Market Closed - Euronext Paris Other stock markets 11:25:00 2024-04-26 am EDT			5-day change	1st Jan Change
1.68 ^EUR	-1.75%		-0.59%	-36.84%

Apr. 08	Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 25	Advicenne: ODD designation in cystinuria	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Advicenne : met à disposition son Document d’Enregistrement Universel 2023	Apr. 08	PU
Advicenne : 2023 Universal Registration Document made available	Apr. 08	PU
Advicenne: Strong improvement of 2023 results thanks to sustained commercial activity on Sibnayal®	Mar. 28	BU
Advicenne - FDA grants Orphan Drug Designation to ADV7103 for the treatment of cystinuria	Mar. 26	AQ
Advicenne : Inside Information / Other news releases	Mar. 25	PU
FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.	Mar. 25	BU
Advicenne reports 2023 gross sales1 up 20% to EUR4.43 million	Jan. 24	AQ
Advicenne announces the results of its capital increase with preferential subscription rights	23-10-03	AQ
Advicenne : October 2, 2023 - Advicenne announces the results of its capital increase with preferential subscription rights	23-10-02	PU
Advicenne reports its First Half Financial results as of June 30, 2023 and updates on its activities	23-09-12	AQ
Advicenne : June 14, 2023 - Advicenne announces long-term results of the European clinical development program for ADV7103	23-06-14	PU
Advicenne : Inside Information / Other news releases	23-06-09	PU
Advicenne : Inside Information / News release on accounts, results	23-03-30	PU
Advicenne : Inside Information / Information on annual revenues	23-01-24	PU
Advicenne : December 5, 2022 - Advicenne announces the second tranche drawdown of its non-dilutive financing agreement with the EIB	22-12-05	PU
Advicenne reports its First Half Financial results as of June 30, 2022	22-09-21	AQ
Advicenne 2021 Universal Registration Document made available	22-05-02	AQ
Advicenne : 29 April, 2022 - Advicenne 2021 Universal Registration Document made available	22-04-29	PU
Advicenne : April 5, 2022 - A case report highlights the interest of a long-term treatment with ADV-7103 in dRTA	22-04-05	PU
Advicenne announces the transfer of its shares from Euronext Paris and Euronext Brussels to Euronext Growth Paris on March 30, 2022	22-03-29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Advicenne

Equities

ALDVI

FR0013296746

Press Releases

Filters